Sight Sciences Inc

+0.18 (+1.76%)
1:08:39 PM EDT: $10.40 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)509.59M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$20.12 Million
Adjusted EPS-$0.41
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Sight Sciences Inc Stock, NASDAQ:SGHT

4040 Campbell Avenue, Suite 100, Menlo Park, California 94025
United States of America
Phone: +1.877.266.1144
Number of Employees: 212


Sight Sciences, Inc. is a medical device company, which engages in the provision of glaucoma implants for treatment of irreversible blindness. It also develops pharmaceuticals, drug delivery systems, and diagnostics for the treatment of ophthalmic conditions. The firm's products include viscosurgical system and trabeculotomy instruments. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.